acridines has been researched along with Malignant Melanoma in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (45.45) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cichorek, M; Deptuła, M; Dzierzbicka, K; Gensicka-Kowalewska, M; Klejbor, I; Ronowska, A | 1 |
| Gately, S; Goodall, ML; Kauffman, AL; Kortus, MG; MacKeigan, JP; Martin, KR; Trent, JM; Wang, T | 1 |
| Henderson, CJ; MacLeod, AK; McLaughlin, LA; Wolf, CR | 1 |
| Amodei, S; Antonelli, A; Benassi, B; Biroccio, A; D'Angelo, C; D'Incalci, M; Elli, R; Leonetti, C; Rizzo, A; Stevens, MF; Zupi, G | 1 |
| Jordan, RT; Pardini, RS | 1 |
| Baguley, BC; Marshall, E; Zhuang, L | 1 |
| Baguley, BC; Finlay, GJ; Marshall, E; Matthews, JH; Paull, KD | 1 |
| Boratyński, J; Duś, D; Kuśnierczyk, H; Paprocka, M; Radzikowski, C | 1 |
| Charlton, PA; Cree, IA; Neale, MH | 1 |
| Aboagye, EO; Baguley, BC; Brady, F; Brown, GD; Denny, WA; Gamage, SA; Luthra, SK; Myers, R; Osman, S; Price, PM; Rowlinson-Busza, G | 1 |
| Miller, DM; Stewart, DA; Thomas, SD; Xu, X | 1 |
| Kohen, C; Kohen, E; Leising, HB; Marty, A; Salmon, JM; Schachtschabel, DO; Thorell, B; Viallet, P | 1 |
| Cysyk, RL; Legha, SS; Shoemaker, DD | 1 |
| Benjamin, RS; Bodey, GP; Burgess, MA; Gutterman, JU; Hall, SW; Legha, SS; Valdivieso, M | 1 |
| Baguley, BC; Finlay, GJ | 1 |
| Kapp, A; Komann, A; Schöpf, E | 1 |
| Balda, BR; Birkmayer, GD | 3 |
| Balda, BR; Birkmayer, G | 1 |
| Auersperg, N; Tan, P | 1 |
| Atwell, GJ; Cain, BF | 1 |
22 other study(ies) available for acridines and Malignant Melanoma
| Article | Year |
|---|---|
Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents.
Topics: Acridines; Acridones; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Structure; Structure-Activity Relationship | 2019 |
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.
Topics: Acridines; Animals; Antimalarials; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Indoles; Lysosomes; Melanoma; Mice; Mutation; Proto-Oncogene Proteins B-raf; Structure-Activity Relationship; Sulfonamides; Translational Research, Biomedical; Tumor Stem Cell Assay; Vemurafenib | 2014 |
Activation status of the pregnane X receptor influences vemurafenib availability in humanized mouse models.
Topics: Acridines; Animals; Biological Availability; Biological Transport; Cell Line, Tumor; Constitutive Androstane Receptor; Cytochrome P-450 CYP3A; Female; Indoles; Male; Melanoma; Mice; Mice, Knockout; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Sulfonamides; Tetrahydroisoquinolines; Vemurafenib | 2015 |
Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
Topics: Acridines; Apoptosis; Cell Cycle; Cellular Senescence; Humans; Ligands; Melanoma; Telomere; Tumor Cells, Cultured | 2004 |
Anti-neoplastic activity of C205: a new topical anti-cancer formulation.
Topics: Acridines; Administration, Topical; Animals; Antineoplastic Agents; Drug Evaluation, Preclinical; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Skin Neoplasms | 1984 |
Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide.
Topics: Acridines; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Humans; Intercalating Agents; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Regression Analysis; Time Factors; Transplantation, Heterologous | 1995 |
In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance.
Topics: Acridines; Aminoacridines; Antineoplastic Agents; DNA Topoisomerases, Type I; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Leukemia; Melanoma; Tumor Cells, Cultured | 1993 |
Conjugation of the monoclonal antibody 17-1A with the nitroacridine compound C921 with the poly-L-lysine as an intermediate agent.
Topics: Acridines; Adenocarcinoma; Antibodies, Monoclonal; Antibody Specificity; Colonic Neoplasms; Flow Cytometry; Humans; Immunotoxins; Melanoma; Polylysine; Tumor Cells, Cultured | 1997 |
Ex vivo activity of XR5000 against solid tumors.
Topics: Acridines; Adenosine Triphosphate; Adult; Aged; Antineoplastic Agents; DNA, Neoplasm; Dose-Response Relationship, Drug; Female; Humans; Luminescent Measurements; Male; Melanoma; Middle Aged; Ovarian Neoplasms; Skin Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2000 |
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Topics: Acridines; Animals; Antineoplastic Agents; Carbon Radioisotopes; Female; Glioma; HT29 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; Isotope Labeling; Melanoma; Mice; Mice, Inbred ICR; Mice, Nude; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
Topics: Acridines; Animals; Apoptosis; Base Sequence; Blotting, Western; Cell Division; Cisplatin; Disease Progression; Drug Synergism; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Genes, myc; In Situ Nick-End Labeling; Melanoma; Mice; Mice, Inbred C57BL; Oligonucleotides, Antisense; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Tumor Cells, Cultured | 2002 |
The effect of atebrine and an acridine analog (BCMA) on the coenzyme fluorescence spectra of cultured melanoma and Ehrlich ascites (EL2) cells.
Topics: Acridines; Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cell Line; DNA, Neoplasm; Melanoma; NAD; NADP; Neoplasm Proteins; Quinacrine; Spectrometry, Fluorescence | 1978 |
Selective localization of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in B 16 melanoma.
Topics: Acridines; Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Male; Melanoma; Mesylates; Mice; Neoplasms, Experimental; Time Factors | 1978 |
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Marrow; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Phenylenediamines; Remission, Spontaneous | 1978 |
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Effect of tumour necrosis factor alpha in vivo on human granulocyte oxidative metabolism.
Topics: Acridines; Amino Acid Sequence; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Luminescent Measurements; Lymphotoxin-alpha; Melanoma; Molecular Sequence Data; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidation-Reduction; Recombinant Proteins; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 1991 |
Drug effects in melanoma: tumor-specific interactions of proflavine and ethidiumbromide.
Topics: Acridines; Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Centrifugation, Density Gradient; Coloring Agents; Cricetinae; Depression, Chemical; Diamines; DNA, Neoplasm; Ethidium; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenic Viruses; Reverse Transcriptase Inhibitors; RNA; RNA Viruses; RNA, Neoplasm; Templates, Genetic; Tritium; Uridine | 1973 |
[Nucleic acid and protein synthesis in hamster melanoma under the influence of drugs. I. In vivo studies of DNA synthesis in hamster melanoma].
Topics: Acridines; Animals; Cell Nucleus; Cricetinae; DNA, Neoplasm; Melanoma; Mitochondria; Neoplasm Proteins; Neoplasms, Experimental; Thymidine; Tritium | 1970 |
[Nucleic acid and protein synthesis in hamster melanoma under the action of drugs. II. In vivo studies of protein synthesis in hamster melanoma following treatment with proflavin, chloramphenicol and D-penicillamine].
Topics: Acridines; Animals; Cell Nucleus; Chloramphenicol; Cricetinae; Melanoma; Mitochondria; Neoplasm Proteins; Neoplasms, Experimental; Penicillamine; Phenylalanine; Ribosomes; Stereoisomerism; Tritium | 1970 |
Effects of the antineoplastic alkaloid acronycine on the ultrastructure and growth patterns of cultured cells.
Topics: Acridines; Alkaloids; Animals; Antineoplastic Agents; Cell Adhesion; Cell Division; Cell Line; Cell Nucleus; Cells, Cultured; Cyclic AMP; Cytochalasin B; Female; Golgi Apparatus; Humans; Leukemia, Experimental; Leukemia, Lymphoid; Melanoma; Mice; Microscopy, Electron; Mitochondria; Mitosis; Simian virus 40; Time Factors; Tumor Virus Infections; Uterine Cervical Neoplasms | 1973 |
The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.
Topics: Acridines; Animals; Anisoles; Antineoplastic Agents; Chemical Phenomena; Chemistry, Physical; Cytarabine; Dose-Response Relationship, Drug; Injections, Intradermal; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Leukemia L1210; Leukemia, Experimental; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phenylenediamines; Skin Neoplasms; Structure-Activity Relationship; Sulfones | 1974 |
[Effects of proflavine on DNA metabolism in hamster melanoma].
Topics: Acridines; Animals; Antimetabolites; Cell Nucleus; Cricetinae; DNA, Neoplasm; Female; Liver; Melanoma; Mitochondria; Mitochondria, Liver; Thymidine; Tritium | 1970 |